Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe
Overview
Authors
Affiliations
Background: Male circumcision devices have the potential to accelerate voluntary medical male circumcision roll-out, with PrePex being one promising device. Here, we present findings on safety and acceptability from active surveillance of the implementation of PrePex among 1000 males circumcised in Zimbabwe.
Methods: The first 1000 men consecutively circumcised using PrePex during routine service delivery were actively followed up. Outcome measures included PrePex uptake, attendance for postcircumcision visits, and adverse events (AEs). A survey was conducted among 500 consecutive active surveillance clients to assess acceptability and satisfaction with PrePex.
Results: A total of 2156 men aged 18 years or older were circumcised across the 6 PrePex active surveillance sites. Of these, 1000 (46.4%) were circumcised using PrePex. Among them, 4 (0.4%) self-removals that required surgery (severe AEs) were observed. Six (0.6%) removals by providers (moderate AEs) did not require surgery. A further 280 (28%) AEs were mild or moderate pain during device removal. There were also 12 (1.2%) moderate AEs unrelated to pain. All AEs resolved without sequelae. There was high adherence to follow-up appointments, with 97.7% of clients attending the scheduled day 7 visit. Acceptability of PrePex was high among survey participants, 93% indicated willingness to recommend the device to peers. Of note, 95.8% of respondents reported experiencing pain when the device was being removed. Additionally, 85.2% reported experiencing odor while wearing the device or during removal.
Conclusions: Active surveillance of the first 1000 men circumcised using PrePex suggests that the device is both safe and acceptable when used in routine service delivery.
Tabei S, Raheem O Int J Impot Res. 2024; .
PMID: 38971896 DOI: 10.1038/s41443-024-00947-x.
Mavhu W, Hatzold K, Madidi N, Maponga B, Dhlamini R, Munjoma M PLoS One. 2019; 14(3):e0213399.
PMID: 30856228 PMC: 6411138. DOI: 10.1371/journal.pone.0213399.
PrePex circumcision surveillance: Adverse events and analgesia for device removal.
Lebina L, Milovanovic M, Otwombe K, Abraham P, Manentsa M, Nzenze S PLoS One. 2018; 13(3):e0194271.
PMID: 29579082 PMC: 5868790. DOI: 10.1371/journal.pone.0194271.
VMMC Devices-Introducing a New Innovation to a Public Health Intervention.
Ridzon R, Reed J, Sgaier S, Hankins C J Acquir Immune Defic Syndr. 2016; 72 Suppl 1:S1-4.
PMID: 27331583 PMC: 4936419. DOI: 10.1097/QAI.0000000000000967.